DM
Drunal Mansukhlal Shah
About Drunal Mansukhlal Shah
Data last updated:
Drunal Mansukhlal Shah is a Director at Dimetrics Chemicals Private Limited (since 2011). The companies operate in Chemicals and Materials and Chemicals. Dimetrics Chemicals Private Limited reported revenue of ₹14.49 Cr (FY 2024). Earlier, Drunal Mansukhlal Shah was a Director at Sharon Bio-Medicine Limited (2009–2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Jun 2011 | 2011 | ₹14.49 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Sep 2009 | 1989 | ₹204 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Drunal Mansukhlal Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhavesh Dharnendra Shah | 03434804 | Dimetrics Chemicals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Drunal Mansukhlal Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Drunal Mansukhlal Shah
Drunal Mansukhlal Shah currently holds 1 directorship: Dimetrics Chemicals Private Limited (Director, since 03 Jun 2011, revenue ₹14.49 Cr (FY 2024)).
Drunal Mansukhlal Shah was first appointed on 25 Sep 2009 as Director at Sharon Bio-Medicine Limited. The most recent appointment on record is 03 Jun 2011 at Dimetrics Chemicals Private Limited.
Drunal Mansukhlal Shah held 1 earlier board appointment: Sharon Bio-Medicine Limited (Director, 25 Sep 2009 to 01 Sep 2013).
The current boards of Drunal Mansukhlal Shah's companies include Bhavesh Dharnendra Shah (Dimetrics Chemicals Private Limited).